Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Kimmel Cancer Center (KCC) National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00893295 |
RATIONALE: Screening may help doctors find colorectal cancer sooner, when it may be easier to treat. Finding out what affects a patient's decision to undergo screening tests may help increase the number of patients who undergo regular screening for cancer. It is not yet known whether personalized invitations to undergo colorectal cancer screening are more effective than standard screening reminders.
PURPOSE: This randomized phase III trial is studying ways to increase colorectal cancer screening in African Americans.
Condition | Intervention | Phase |
---|---|---|
Colorectal Cancer |
Other: informational intervention Other: medical chart review Other: screening questionnaire administration Procedure: barium enema injection Procedure: colon imaging study Procedure: screening colonoscopy Procedure: sigmoidoscopy Procedure: study of socioeconomic and demographic variables |
Phase III |
Study Type: | Interventional |
Study Design: | Screening, Randomized, Open Label |
Official Title: | Increasing Colon Cancer Screening in Primary Care Among African Americans |
Estimated Enrollment: | 896 |
Study Start Date: | February 2008 |
Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: This is a multicenter study. Participants are stratified according to practice. Participants are randomized to 1 of 2 intervention arms.
Those participants who have undergone screening will be congratulated for taking the time and preventative action, and be encouraged to continue future screenings. After 45 days, participants who have not been screened receive a reminder letter.
Participants are assessed by a baseline survey consisting of personal background, cognitive and psychological representations, social support and influence, intention, and decision stage related to screening SBT and colonoscopy preference. Data obtained from the endpoint survey assessing whether participants and their providers discussed CRC screening before the study and opinions about the intervention, and an endpoint chart audit to gather data on participant CRC screening exam dates and exam results (i.e., screening SBT, flexible sigmoidoscopy, colonoscopy, double-contrast barium enema [DCBE] x-ray) are assessed for group differences.
Ages Eligible for Study: | 50 Years to 79 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Pennsylvania | |
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia | Recruiting |
Philadelphia, Pennsylvania, United States, 19107-5541 | |
Contact: Clinical Trials Office - Kimmel Cancer Center at Thomas Jeffer 215-955-6084 |
Principal Investigator: | Ronald Myers, PhD | Jefferson Medical College of Thomas Jefferson University |
Responsible Party: | Jefferson Medical College of Thomas Jefferson University ( Ronald Myers ) |
Study ID Numbers: | CDR0000635953, TJUH-RSGT-08-017-01-CPPB, 08G.89 |
Study First Received: | May 2, 2009 |
Last Updated: | May 2, 2009 |
ClinicalTrials.gov Identifier: | NCT00893295 History of Changes |
Health Authority: | Unspecified |
colon cancer rectal cancer |
Rectal Cancer Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Rectal Neoplasms Colonic Diseases |
Rectal Neoplasm Gastrointestinal Neoplasms Intestinal Diseases Rectal Diseases Intestinal Neoplasms Colorectal Neoplasms |
Neoplasms Digestive System Diseases Neoplasms by Site Digestive System Neoplasms Gastrointestinal Diseases Colonic Diseases |
Gastrointestinal Neoplasms Intestinal Diseases Rectal Diseases Intestinal Neoplasms Colorectal Neoplasms |